Navigation Links
Imagenetix, Inc. Reports First Quarter 2011 Results
Date:8/17/2010

SAN DIEGO, Aug. 17 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year.   Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.  

Commenting on the results of the first quarter, Mr. William Spencer, Imagenetix Chief Executive Officer said: "Sales and earnings were negatively impacted from the company's investment and transition to our mass retail branded products – Celadrin softgels, Celadrin cream and BioGuard, our novel healthy immune system innovation. Forward looking, Imagenetix expects to reflect the benefits of its retail strategy in the form of sequentially and significantly stronger quarterly sales. Branded product shipments combined with favorable in-store turnover, gives us the confidence in our retail brand strategy and building both short and long term value for our shareholders."

About Imagenetix

Imagenetix, based in San Diego, California, is an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health on a global basis.  Imagenetix develops and formulates propriety over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution.  In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners.  Imagenetix is the creator of Celadrin®.  Please visit, www.celadrin.com, www.bioguardhealth.com or www.imagenetix.net.

Certain matters in this news release are forward-looking statements which are subject to risks and uncertainties that could cause actual results to vary materially from those projected.  Such risks and uncertainties include, but are not limited to, adverse fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company's products and services.  Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in the company's SEC filings, including its Form 10-K for the year ended March 31, 2009.Contact   Imagenetix Investor Relations

William P. Spencer(858)385-2797

Chief Executive OfficerImagenetix, Inc.Tel: (858) 674-8455Imagenetix, Inc.Condensed Consolidated Statements of Operations(Unaudited)(In thousands, except per share data)Three Months EndedJune 30,20102009Net sales$

1,085$

1,702   Cost of sales7501,055Gross profit335647Gross profit percent30.9%38.0%Operating expenses:General and administrative596808Payroll expense243255Consulting expense410280Operating expenses 1,2491,343Operating income (loss)(914)(696)Other income11Interest expense (89)(2)Income (loss) before income taxes(1,002)(697)Income tax expense (benefit)(398)(282)Net income (loss)$

(604)$

(415)Income (loss) per share:Basic$

(0.05)$

(0.04)Diluted$

(0.05)$

(0.04)Weighted average common shares outstanding:Basic11,31011,011Diluted11,31011,011Imagenetix, Inc. Condensed Consolidated Balance Sheets(Unaudited)(In thousands) June 30,  March 31, 2010 2010 Assets:Current assets:Cash and cash equivalents

$

594$

981Accounts receivable, net9141,049Inventories, net1,2971,350Prepaid expenses and other current assets188151Deferred tax asset1,328933   Total current assets4,3214,464Property and equipment, net 8189Long-term prepaid expenses1518Other assets 122125   Total assets

$

4,539$

4,696Liabilities and stockholders' equity:Current liabilities:Secured note payable to bank

$

500$

-Accounts payable525997Accrued liabilities7883Customer deposits1925Contract payable4386   Total current liabilities1,1651,191Stockholders' equity 3,3743,505   Total liabilities and stockholders' equity

$

4,539$

4,696
'/>"/>

SOURCE Imagenetix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Imagenetix, Inc. Reports Second Quarter and Six Month Results
2. Imagenetix, Inc. Reports First Quarter 2010 Results
3. Imagenetix, Inc. Announces Interview With Bloomberg Radio
4. Imagenetix, Inc. to Present at the 2009 RedChip New York Equities Conference
5. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
6. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
7. Par Pharmaceutical Reports Second Quarter 2008 Results
8. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
9. Pharmos Corporation Reports 2008 Second Quarter Results
10. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
11. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Irvine, ca (PRWEB) , ... October 12, 2017 ... ... for the Surgical Wound Market with the addition of its newest module, US ... the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
Breaking Biology Technology:
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
Breaking Biology News(10 mins):